Industry & Business

Construction to start on GCP2 Production Facility at Takeda Ireland Ltd site

 Breaking News
  • SEAI and OPW Partner on Energy Saving Pilot Programme The Sustainable Energy Authority of Ireland (SEAI) is working in partnership with the Office of Public Works (OPW) to help make government buildings more energy and cost efficient with the added benefit of making them warmer and healthier places to work. The Central Government Building Upgrade Fund, funded by SEAI and administered by the OPW, [...]...
  • British Institute of Facilities Management Ireland Region Awards Launched The search is on for top facilities management talent across Ireland as the British Institute of Facilities Management (BIFM) Ireland region launches this year’s BIFM Ireland Region Awards. The prestigious awards will be celebrated at the industry body’s 21st annual FM Summit which returns to the newly refurbished National Stadium at Windsor Park in Belfast [...]...
  • Keelings Raises Over €15,000 For Dyslexia Association of Ireland Keelings, Ireland’s leading producer and supplier of fresh fruit, has raised €15,556.50 for Dyslexia Association Ireland. Founded in 1972, the Dyslexia Association of Ireland works with people affected by dyslexia, by providing information, offering appropriate support services, engaging in advocacy, and raising awareness of dyslexia. Dyslexia is a learning difficulty, which affects the capacity for fluent and [...]...
  • New Directors Steer MaREI’s Vision For Ireland as Energy Leader MaREI, Ireland’s national centre for marine and renewable energy research and development, has appointed UCC professors Brian Ó Gallachóir and Jerry Murphy as its new co-directors, after the Citizens’ Assembly recently turned its attention to tackling climate change. The Assembly’s efforts align with MaREI’s vision to make Ireland a global leader in marine and renewable energy [...]...
  • ABP Food Group in £22 Million Renewable Energy Project A £22 million investment by ABP Food Group’s renewable division in a green energy plant in the UK will produce enough sustainable energy to power the equivalent of 12,000 homes.  ABP’s renewables division, Olleco, has just opened the new 15 MW Anaerobic Digestion facility in Aylesbury, Buckinghamshire. The ABP Food Group facility is located adjacent to [...]...

Construction to start on GCP2 Production Facility at Takeda Ireland Ltd site

Construction to start on GCP2 Production Facility at Takeda Ireland Ltd site
June 01
09:00 2017

Takeda Pharmaceutical Company Limited has announced that a groundbreaking ceremony has been held for its new production facility at the existing Grange Castle site in Ireland. Takeda’s existing footprint at the Grange Castle site will be expanded with the construction of a new standalone, high-containment production facility dedicated to manufacturing its oncology product NINLARO for global markets. The investment will create approximately 40 new jobs over the next two years.

“Our new plant in Grange Castle, Ireland is a strategic investment for Takeda,” said Thomas Wozniewski, Head of Global Manufacturing & Supply. “It will give us the crucial in-house manufacturing capacity to meet the increasing demand for our innovative product NINLARO.”

The construction of the plant, which begins in June 2017, will be managed by Project Management Group with over €40 million investment in total. The plant is scheduled to be completed in Q2 FY18 and become operational to commence shipment of secondary packaged product in the second half of FY18.

The new production facility will be unique in that it will house the Drug Substance, Drug Product, Primary and Secondary Packaging and QC processes all under one roof.

NINLARO was approved in November 2015 by the U.S. Food and Drug Administration (FDA). It is the first and only once-weekly oral proteasome inhibitor launched in the U.S. for the treatment of patients with multiple myeloma who have received at least one prior therapy, enabling an all-oral proteasome inhibitor-based triplet treatment regimen for the first time. Additionally, NINLARO® was approved by the Japanese Ministry of Health, Labour and Welfare in March 2017 and launched in May as the first oral proteasome inhibitor in Japan, indicated in combination with lenalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma.

About Author

editor

editor

Related Articles






New Subscriber





Subscribe Here



Advertisements
































National Manufacturing Conference & Exhibition 2016

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4